Related Experiment Video

Updated: May 25, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1

F Rizzolio1, C Lucchetti, I Caligiuri

  • 1Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA.

Cell Death and Differentiation
|February 11, 2012
PubMed

Insights

Pin1 protein regulates cell proliferation by controlling retinoblastoma protein (pRb) phosphorylation. Targeting both Pin1 and CDK shows promise for effective cancer treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Uncontrolled cell proliferation in cancer is often linked to retinoblastoma protein (pRb) inactivation via phosphorylation.
  • Cyclin-dependent kinase (CDK)/cyclin complexes and CDK inhibitors play critical roles in cell cycle regulation and cancer development.

Purpose of the Study:

  • To investigate the role of Pin1 (protein interacting with NIMA-1), a peptidylprolyl isomerase, in the regulation of pRb phosphorylation and cell proliferation.
  • To elucidate the mechanism by which Pin1 influences pRb inactivation and its implications in human cancer.

Main Methods:

  • Studied the interaction between Pin1 and pRb.
  • Analyzed the effect of Pin1 on pRb phosphorylation at specific sites (Ser 608/612).
  • Investigated the involvement of the CDK pathway in the Pin1-pRb interaction.

Main Results:

  • Pin1 directly interacts with the spacer domain of pRb, specifically at the phosphorylated Ser 608/612 motif.
  • Pin1 facilitates the interaction between CDK/cyclin complexes and pRb, promoting pRb hyper-phosphorylation in mid/late G1 phase.
  • Pin1's action on pRb phosphorylation occurs independently of CDK and protein phosphatase 1 and 2 activity.

Conclusions:

  • Pin1 is an essential mediator for pRb inactivation, selectively boosting its hyper-phosphorylation in tumor cells.
  • The CDK pathway is crucial for the interaction between Pin1 and pRb.
  • Combined inhibition of CDK and Pin1 presents a promising therapeutic strategy for cancer treatment, potentially offering high efficacy at tolerable doses.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...